Pharmacologic interruption of the renin-angiotensin system in myohemoglobinuric acute renal failure.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000503:physiopathology*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D004305:Dose-Response Relationship, Drug; D005990:Glycerol; D007668:Kidney / Q000098:blood supply; D008297:Male; D009212:Myoglobinuria / Q000503:physiopathology*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D013722:Teprotide / Q000008:administration & dosage; D014655:Vascular Resistance / Q000187:drug effects; D000092502:Renin Inhibitors
D000804:Angiotensin II; D005990:Glycerol; D013722:Teprotide; D000092502:Renin Inhibitors